Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19
Clinical trial NCT05079217 · UNKNOWN
Trial details
- NCT number
- NCT05079217
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2021-12-21
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.